Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04168580 · ClinicalTrials.gov registry record · NA

Brown Adipose Tissue as a Therapeutic for the Metabolic and Cardiac Dysfunction With Senescence (BATSR)

A NA study, sponsored by AdventHealth Translational Research Institute.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT04168580: Completed NA study, sponsored by AdventHealth Translational Research Institute.

NCT04168580 is a NA study that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04168580, a NA study, has completed, sponsored by AdventHealth Translational Research Institute.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The goal of this study is to define the effect of aging on brown adipose tissue mass in a cohort of older sedentary and older athlete adults.

Primary Outcome

Supraclavicular Adipose Tissue Proton Density Fat Fraction Percentage (PDFF %) is the primary outcome. PDFF % is determined by MRI

Interventions

  • OTHER Exercise Training Intervention

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2020-10-20
Est. Completion 2024-02-23
Phase NA

What the finished NCT04168580 record still lists

NCT04168580 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Exercise Training Intervention is the first listed.

NCT04168580 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04168580 about?

NCT04168580 is a clinical study titled "Brown Adipose Tissue as a Therapeutic for the Metabolic and Cardiac Dysfunction With Senescence (BATSR)". The goal of this study is to define the effect of aging on brown adipose tissue mass in a cohort of older sedentary and older athlete adults.

What is the current status of trial NCT04168580?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2020-10-20. Estimated completion is 2024-02-23.

What interventions are being tested in trial NCT04168580?

The interventions under investigation include: Exercise Training Intervention (OTHER).

Who is sponsoring clinical trial NCT04168580?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04168580's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04168580, the US trial registry maintained by the National Library of Medicine. NCT04168580 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.